Currently, dopaminomimetics and monoamine oxidase B (MAO-B) inhibitors are utilized to suppress dopamine decomposition in PD therapy, nevertheless, they simply treat symptoms and have severe side effects [1]
Angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) binds at the AT 1 receptor subtype and mediates systemic blood pressure, body water/electrolyte balance and influences cerebral blood flow, cerebroprotection, seizure, stress and depression
The facility was established to address what was lacking in many hospital emergency rooms: time-sensitive healthcare services
Zak A, Siwinska N, Elzinga S, et al
Recalls & Warnings January 04, 2007 Sellers of Popular Weight Loss Supplements Pay $25 Million Over FTC Allegations of Deceptive Advertising On January 4, 2007, the Federal Trade Commission (FTC) announced that it had filed complaints in four separate cases alleging that weight-loss and weight-control claims were not supported by competent and reliable scientific evidence.
